CoChat
Cited by 33

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Low-dose zinc oxide nanoparticles trigger the growth and biofilm formation of Pseudomonas aeruginosa: a hormetic response

Al-Momani, Hafez, Aolymat, Iman, Ibrahim, Lujain, Albalawi, Hadeel, Al Balawi, Dua’a, Albiss, Borhan Aldeen, Almasri, Muna, Alghweiri, Sahar · 2024 · BMC Microbiology

Abstract

INTRODUCTION: Hormesis describes an inverse dose-response relationship, whereby a high dose of a toxic compound is inhibitory, and a low dose is stimulatory. This study explores the hormetic response of low concentrations of zinc oxide nanoparticles (ZnO NPs) toward Pseudomonas aeruginosa. METHOD: Samples of P. aeruginosa, i.e. the reference strain, ATCC 27,853, together with six strains recovered from patients with cystic fibrosis, were exposed to ten decreasing ZnO NPs doses (0.78-400 µg/mL). The ZnO NPs were manufactured from Peganum harmala using a chemical green synthesis approach, and their properties were verified utilizing X-ray diffraction and scanning electron microscopy. A microtiter plate technique was employed to investigate the impact of ZnO NPs on the growth, biofilm formation and metabolic activity of P. aeruginosa. Real-time polymerase chain reactions were performed to determine the effect of ZnO NPs on the expression of seven biofilm-encoding genes. RESULT: The ZnO NPs demonstrated concentration-dependent bactericidal and antibiofilm efficiency at concentrations of 100-400 µg/mL. However, growth was significantly stimulated at ZnO NPs concentration of 25 µg/mL (ATCC 27853, Pa 3 and Pa 4) and at 12.5 µg/mL and 6.25 µg/mL (ATCC 27853, Pa 2, Pa 4 and Pa 5). No significant positive growth was detected at dilutions < 6.25 µg/mL. similarly, biofilm formation was stimulated at concentration of 12.5 µg/mL (ATCC 27853 and Pa 1) and at 6.25 µg/mL (Pa 4). At concentration of 12.5 µg/mL, ZnO NPs upregulated the expression of LasB ( ATCC 27853, Pa 1 and Pa 4) and LasR and LasI (ATCC 27853 and Pa 1) as well as RhII expression (ATCC 27853, Pa 2 and Pa 4). CONCLUSION: When exposed to low ZnO NPs concentrations, P. aeruginosa behaves in a hormetic manner, undergoing positive growth and biofilm formation. These results highlight the importance of understanding the response of P. aeruginosa following exposure to low ZnO NPs concentrations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12866-024-03441-y

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 83

  1. Ciofu O, Tolker-Nielsen T. Tolerance and resistance of Pseudomonas aeruginosa biofilms to antimicrobial agents—how P. Aeruginosa can escape antibiotics. Front Microbiol. 2019;10:913. · DOI · Paper page
  2. Azam MW, Khan AU. Updates on the pathogenicity status of Pseudomonas aeruginosa. Drug Discovery Today. 2019;24(1):350–9. · DOI · Paper page
  3. Lund-Palau H, Turnbull AR, Bush A, Bardin E, Cameron L, Soren O, et al. Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches. Expert Rev Respir Med. 2016;10(6):685–97. · DOI · Paper page
  4. Faure E, Kwong K, Nguyen D. Pseudomonas aeruginosa in chronic lung infections: how to adapt within the host? Front Immunol. 2018;9:2416. · DOI · Paper page
  5. Kamali E, Jamali A, Ardebili A, Ezadi F, Mohebbi A. Evaluation of antimicrobial resistance, biofilm forming potential, and the presence of biofilm-related genes among clinical isolates of Pseudomonas aeruginosa. BMC Res Notes. 2020;13(1):1–6. · DOI · Paper page
  6. Castillo-Juárez I, Maeda T, Mandujano-Tinoco EA, Tomás M, Pérez-Eretza B, García-Contreras SJ, et al. Role of quorum sensing in bacterial infections. World J Clin Cases: WJCC. 2015;3(7):575. · DOI · Paper page
  7. Brindhadevi K, LewisOscar F, Mylonakis E, Shanmugam S, Verma TN, Pugazhendhi A. Biofilm and Quorum sensing mediated pathogenicity in Pseudomonas aeruginosa. Process Biochem. 2020;96:49–57. · DOI · Paper page
  8. Singh S, Singh SK, Chowdhury I, Singh R. Understanding the mechanism of bacterial biofilms resistance to antimicrobial agents. open Microbiol J. 2017;11:53. · DOI · Paper page
  9. Urban-Chmiel R, Marek A, Stępień-Pyśniak D, Wieczorek K, Dec M, Nowaczek A, et al. Antibiotic Resist Bacteria—A Rev Antibiot. 2022;11(8):1079.
  10. Espitia PJP, Soares NFF, Coimbra JSR, de Andrade NJ, Cruz RS, Medeiros EAA. Zinc oxide nanoparticles: synthesis, antimicrobial activity and food packaging applications. Food Bioprocess Technol. 2012;5(5):1447–64. · DOI · Paper page
  11. Singh P, Nanda A. Antimicrobial and antifungal potential of zinc oxide nanoparticles in comparison to conventional zinc oxide particles. J Chem Pharm Res. 2013;5:457–63.
  12. Reddy KM, Feris K, Bell J, Wingett DG, Hanley C, Punnoose A. Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems. Appl Phys Lett. 2007;90(21):213902. · DOI · Paper page
  13. Kumar R, Umar A, Kumar G, Nalwa HS. Antimicrobial properties of ZnO nanomaterials: a review. Ceram Int. 2017;43(5):3940–61. · DOI · Paper page
  14. Abebe B, Zereffa EA, Tadesse A, Murthy HA. A review on enhancing the antibacterial activity of ZnO: mechanisms and microscopic investigation. Nanoscale Res Lett. 2020;15:1–19. · DOI · Paper page
  15. Zhang L, Jiang Y, Ding Y, Povey M, York D. Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids). J Nanopart Res. 2007;9:479–89. · DOI · Paper page
  16. Sirelkhatim A, Mahmud S, Seeni A, Kaus NHM, Ann LC, Bakhori SKM, et al. Review on zinc oxide nanoparticles: antibacterial activity and toxicity mechanism. Nano-micro Lett. 2015;7:219–42. · DOI · Paper page
  17. Babayevska N, Przysiecka Ł, Iatsunskyi I, Nowaczyk G, Jarek M, Janiszewska E, et al. ZnO size and shape effect on antibacterial activity and cytotoxicity profile. Sci Rep. 2022;12(1):8148. · doi:10.1038/s41598-022-12134-3
  18. Guo B-L, Han P, Guo L-C, Cao Y-Q, Li A-D, Kong J-Z, et al. The antibacterial activity of Ta-doped ZnO nanoparticles. Nanoscale Res Lett. 2015;10:1–10. · DOI · Paper page
  19. Keerthana S, Kumar A. Potential risks and benefits of zinc oxide nanoparticles: a systematic review. Crit Rev Toxicol. 2020;50(1):47–71. · DOI
  20. Sahu D, Kannan G, Vijayaraghavan R, Anand T, Khanum F. Nanosized zinc oxide induces toxicity in human lung cells. Int Sch Res Notices. 2013;2013. · DOI
  21. Marwat SK, ur Rehman F. Medicinal and pharmacological potential of harmala (Peganum harmala L.) seeds. Nuts and seeds in Health and Disease Prevention. Elsevier; 2011. pp. 585–99. · DOI
  22. Moloudizargari M, Mikaili P, Aghajanshakeri S, Asghari MH, Shayegh J. Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids. Pharmacogn Rev. 2013;7(14):199. · DOI · Paper page
  23. Jinous A, Fereshteh R. Chemistry, pharmacology and medicinal properties of Peganum harmala L. Afr J Pharm Pharmacol. 2012;6(22):1573–80.
  24. Davarnia B, Shahidi S-A, Karimi-Maleh H, Ghorbani-HasanSaraei A, Karimi F. Biosynthesis of Ag nanoparticle by peganum harmala extract; antimicrobial activity and ability for fabrication of quercetin food electrochemical sensor. Int J Electrochem Sci. 2020;15(3):2549–60. · DOI
  25. Stover C, Pham X, Erwin A, Mizoguchi S, Warrener P, Hickey M, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 2000;406(6799):959. · DOI · Paper page
  26. Al-Momani H, Al Balawi Da, Hamed S, Albiss BA, Almasri M, AlGhawrie H, et al. The impact of biosynthesized ZnO nanoparticles from Olea europaea (Common Olive) on Pseudomonas aeruginosa growth and biofilm formation. Sci Rep. 2023;13(1):5096. · doi:10.1038/s41598-023-32366-1
  27. Beckloff N, Laube D, Castro T, Furgang D, Park S, Perlin D, et al. Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens. Antimicrob Agents Chemother. 2007;51(11):4125–32. · DOI
  28. Stockert JC, Horobin RW, Colombo LL, Blázquez-Castro A. Tetrazolium salts and formazan products in Cell Biology: viability assessment, fluorescence imaging, and labeling perspectives. Acta Histochem. 2018;120(3):159–67. · DOI · Paper page
  29. Grela E, Kozłowska J, Grabowiecka A. Current methodology of MTT assay in bacteria–A review. Acta Histochem. 2018;120(4):303–11. · DOI · Paper page
  30. Sieuwerts S, De Bok FA, Mols E, De Vos WM, van Hylckama Vlieg J. A simple and fast method for determining colony forming units. Lett Appl Microbiol. 2008;47(4):275–8. · DOI · Paper page
  31. Hung C-C, Santschi PH, Gillow JB. Isolation and characterization of extracellular polysaccharides produced by Pseudomonas fluorescens Biovar II. Carbohydr Polym. 2005;61(2):141–7. · doi:10.1016/j.carbpol.2005.04.008
  32. Di Martino P. Extracellular polymeric substances, a key element in understanding biofilm phenotype. AIMS Microbiol. 2018;4(2):274. · DOI · Paper page
  33. Labovská S. Pseudomonas aeruginosa as a cause of nosocomial infections. Pseudomonas aeruginosa-biofilm formation. Infections and Treatments: IntechOpen; 2021.
  34. Ali Z, Mumtaz N, Naz SA, Jabeen N, Shafique M. Multi-drug resistant Pseudomonas aeruginosa: a threat of nosocomial infections in tertiary care hospitals. JPMA. 2015;65(12):12–6.
  35. Vimbela GV, Ngo SM, Fraze C, Yang L, Stout DA. Antibacterial properties and toxicity from metallic nanomaterials. Int J Nanomed. 2017:3941–65. · DOI · Paper page
  36. Gudkov SV, Burmistrov DE, Serov DA, Rebezov MB, Semenova AA, Lisitsyn AB. A mini review of antibacterial properties of ZnO nanoparticles. Front Phys. 2021;9:641481. · DOI · Paper page
  37. Nasrollahzadeh M, Sajjadi M, Sajadi SM, Issaabadi Z. Green nanotechnology. Interface science and technology. Volume 28. Elsevier; 2019. pp. 145–98. · DOI · Paper page
  38. Geraldes AN, da Silva AA, Leal J, Estrada-Villegas GM, Lincopan N, Katti KV, et al. Green nanotechnology from plant extracts: synthesis and characterization of gold nanoparticles. Adv Nanopart. 2016;5(03):176. · DOI
  39. Salem SS, Fouda A. Green synthesis of metallic nanoparticles and their prospective biotechnological applications: an overview. Biol Trace Elem Res. 2021;199:344–70. · DOI · Paper page
  40. Dikshit PK, Kumar J, Das AK, Sadhu S, Sharma S, Singh S, et al. Green synthesis of metallic nanoparticles: applications and limitations. Catalysts. 2021;11(8):902. · DOI · Paper page
  41. Terna AD, Elemike EE, Mbonu JI, Osafile OE, Ezeani RO. The future of semiconductors nanoparticles: synthesis, properties and applications. Mater Sci Engineering: B. 2021;272:115363. · DOI · Paper page
  42. Motelica L, Vasile B-S, Ficai A, Surdu A-V, Ficai D, Oprea O-C, et al. Antibacterial activity of Zinc Oxide nanoparticles loaded with essential oils. Pharmaceutics. 2023;15(10):2470. · DOI
  43. Liu J, Wang Y, Ma J, Peng Y, Wang A. A review on bidirectional analogies between the photocatalysis and antibacterial properties of ZnO. J Alloys Compd. 2019;783:898–918. · DOI · Paper page
  44. da Silva BL, Caetano BL, Chiari-Andréo BG, Pietro RCLR, Chiavacci LA. Increased antibacterial activity of ZnO nanoparticles: influence of size and surface modification. Colloids Surf B. 2019;177:440–7. · DOI · Paper page
  45. Valadbeigi H, Sadeghifard N, Kaviar VH, Haddadi MH, Ghafourian S, Maleki A. Effect of ZnO nanoparticles on biofilm formation and gene expression of the toxin-antitoxin system in clinical isolates of Pseudomonas aeruginosa. Ann Clin Microbiol Antimicrob. 2023;22(1):89. · DOI
  46. Ali SG, Ansari MA, Alzohairy MA, Alomary MN, Jalal M, AlYahya S, et al. Effect of biosynthesized ZnO nanoparticles on multi-drug resistant Pseudomonas aeruginosa. Antibiotics. 2020;9(5):260. · doi:10.3390/antibiotics9050260
  47. García-Lara B, Saucedo‐Mora M, Roldán‐Sánchez J, Pérez‐Eretza B, Ramasamy M, Lee J, et al. Inhibition of quorum‐sensing‐dependent virulence factors and biofilm formation of clinical and environmental Pseudomonas aeruginosa strains by ZnO nanoparticles. Lett Appl Microbiol. 2015;61(3):299–305. · DOI
  48. Calabrese EJ. Hormesis: principles and applications. Homeopathy. 2015;104(02):69–82. · DOI
  49. Li X, Shi J, Sun H, Lin Z. Hormetic dose-dependent response about typical antibiotics and their mixtures on plasmid conjugative transfer of Escherichia coli and its relationship with toxic effects on growth. Ecotoxicol Environ Saf. 2020;205:111300. · DOI
  50. Iavicoli I, Fontana L, Agathokleous E, Santocono C, Russo F, Vetrani I, et al. Hormetic dose responses induced by antibiotics in bacteria: a phantom menace to be thoroughly evaluated to address the environmental risk and tackle the antibiotic resistance phenomenon. Sci Total Environ. 2021;798:149255. · DOI
  51. Agathokleous E, Kitao M, Calabrese EJ. Human and veterinary antibiotics induce hormesis in plants: scientific and regulatory issues and an environmental perspective. Environ Int. 2018;120:489–95. · DOI
  52. Migliore L, Rotini A, Thaller MC. Low doses of tetracycline trigger the E. Coli growth: a case of hormetic response. Dose-response. 2013;11(4):dose–response. 13 – 002. Migliore. · DOI
  53. Yang Y, Alvarez PJ. Sublethal concentrations of silver nanoparticles stimulate biofilm development. Environ Sci Technol Lett. 2015;2(8):221–6. · DOI
  54. Iavicoli I, Leso V, Fontana L, Calabrese EJ. Nanoparticle exposure and hormetic dose–responses: an update. Int J Mol Sci. 2018;19(3):805. · DOI · Paper page
  55. Salem W, Leitner DR, Zingl FG, Schratter G, Prassl R, Goessler W, et al. Antibacterial activity of silver and zinc nanoparticles against Vibrio cholerae and enterotoxic Escherichia coli. Int J Med Microbiol. 2015;305(1):85–95. · DOI · Paper page
  56. Schacht V, Neumann L, Sandhi S, Chen L, Henning T, Klar P, et al. Effects of silver nanoparticles on microbial growth dynamics. J Appl Microbiol. 2013;114(1):25–35. · DOI
  57. Xiu Z-m, Zhang Q-b, Puppala HL, Colvin VL, Alvarez PJ. Negligible particle-specific antibacterial activity of silver nanoparticles. Nano Lett. 2012;12(8):4271–5. · DOI · Paper page
  58. Al-Momani H, Almasri M, Al Balawi DA, Hamed S, Albiss BA, Aldabaibeh N, et al. The efficacy of biosynthesized silver nanoparticles against Pseudomonas aeruginosa isolates from cystic fibrosis patients. Sci Rep. 2023;13(1):8876. · DOI
  59. Rodrigues DF, Elimelech M. Toxic effects of single-walled carbon nanotubes in the development of E. Coli biofilm. Environ Sci Technol. 2010;44(12):4583–9. · doi:10.1021/es1005785
  60. Penesyan A, Gillings M, Paulsen IT. Antibiotic discovery: combatting bacterial resistance in cells and in biofilm communities. Molecules. 2015;20(4):5286–98. · DOI · Paper page
  61. Abdelraheem WM, Mohamed ES. The effect of Zinc Oxide nanoparticles on Pseudomonas aeruginosa biofilm formation and virulence genes expression. J Infect Developing Ctries. 2021;15(06):826–32. · DOI
  62. Fitzpatrick F, Humphreys H, Smyth E, Kennedy C, O’Gara J. Environmental regulation of biofilm formation in intensive care unit isolates of Staphylococcus epidermidis. J Hosp Infect. 2002;52(3):212–8. · DOI
  63. Rachid S, Ohlsen K, Witte W, Hacker W Jr. Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis. Antimicrob Agents Chemother. 2000;44(12):3357–63. · DOI · Paper page
  64. Perrin C, Briandet R, Jubelin G, Lejeune P, Mandrand-Berthelot M-A, Rodrigue A, et al. Nickel promotes biofilm formation by Escherichia coli K-12 strains that produce curli. Appl Environ Microbiol. 2009;75(6):1723–33. · DOI
  65. Landry RM, An D, Hupp JT, Singh PK, Parsek MR. Mucin–Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance. Mol Microbiol. 2006;59(1):142–51. · DOI · Paper page
  66. Wolfmeier H, Pletzer D, Mansour SC, Hancock RE. New perspectives in biofilm eradication. ACS Infect Dis. 2018;4(2):93–106. · DOI · Paper page
  67. van der Heijden J, Vogt SL, Reynolds LA, Peña-Díaz J, Tupin A, Aussel L, et al. Exploring the redox balance inside gram-negative bacteria with redox-sensitive GFP. Free Radic Biol Med. 2016;91:34–44. · DOI
  68. Kaweeteerawat C, Na Ubol P, Sangmuang S, Aueviriyavit S, Maniratanachote R. Mechanisms of antibiotic resistance in bacteria mediated by silver nanoparticles. J Toxicol Environ Health Part A. 2017;80(23–24):1276–89. · DOI · Paper page
  69. Martins D, McKay G, Sampathkumar G, Khakimova M, English AM, Nguyen D. Superoxide dismutase activity confers (p) ppGpp-mediated antibiotic tolerance to stationary-phase Pseudomonas aeruginosa. Proceedings of the National Academy of Sciences. 2018;115(39):9797 – 802. · DOI
  70. Ghorbal SKB, Maalej L, Chourabi K, Khefacha S, Ouzari H-I, Chatti A. Antioxidant defense mechanisms in Pseudomonas aeruginosa: role of iron-cofactored superoxide dismutase in response to UV-C radiations. Curr Microbiol. 2016;73:159–64. · doi:10.1007/s00284-016-1043-7
  71. Su S, Panmanee W, Wilson JJ, Mahtani HK, Li Q, VanderWielen BD, et al. Catalase (KatA) plays a role in protection against anaerobic nitric oxide in Pseudomonas aeruginosa. PLoS ONE. 2014;9(3):e91813. · DOI
  72. da Cruz Nizer WS, Inkovskiy V, Versey Z, Strempel N, Cassol E, Overhage J. Oxidative stress response in Pseudomonas aeruginosa. Pathogens. 2021;10(9):1187. · DOI · Paper page
  73. Strempel N, Nusser M, Neidig A, Brenner-Weiss G, Overhage J. The oxidative stress agent hypochlorite stimulates c-di-GMP synthesis and biofilm formation in Pseudomonas aeruginosa. Front Microbiol. 2017;8:2311. · DOI
  74. Fazli M, Almblad H, Rybtke ML, Givskov M, Eberl L, Tolker-Nielsen T. Regulation of biofilm formation in P seudomonas and B urkholderia species. Environ Microbiol. 2014;16(7):1961–81. · DOI · Paper page
  75. Xu Y, Wang C, Hou J, Dai S, Wang P, Miao L, et al. Effects of ZnO nanoparticles and Zn2 + on fluvial biofilms and the related toxicity mechanisms. Sci Total Environ. 2016;544:230–7. · DOI
  76. Fu PP, Xia Q, Hwang H-M, Ray PC, Yu H. Mechanisms of nanotoxicity: generation of reactive oxygen species. J food drug Anal. 2014;22(1):64–75. · DOI · Paper page
  77. Yu Z, Li Q, Wang J, Yu Y, Wang Y, Zhou Q, et al. Reactive oxygen species-related nanoparticle toxicity in the biomedical field. Nanoscale Res Lett. 2020;15(1):115. · DOI · Paper page
  78. Singh TA, Sharma A, Tejwan N, Ghosh N, Das J, Sil PC. A state of the art review on the synthesis, antibacterial, antioxidant, antidiabetic and tissue regeneration activities of zinc oxide nanoparticles. Adv Colloid Interface Sci. 2021;295:102495. · DOI · Paper page
  79. Kamat A, Badrinarayanan A. SOS-independent bacterial DNA damage responses: diverse mechanisms, unifying function. Curr Opin Microbiol. 2023;73:102323. · DOI
  80. Ahmed MN, Porse A, Sommer MOA, Høiby N, Ciofu O. Evolution of antibiotic resistance in biofilm and planktonic Pseudomonas aeruginosa populations exposed to subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother. 2018;62(8). https://doi.org/10.1128/aac. 00320 – 18. · DOI · Paper page
  81. Vincent MS, Uphoff S. Bacterial phenotypic heterogeneity in DNA repair and mutagenesis. Biochem Soc Trans. 2020;48(2):451–62. · DOI
  82. Dawan J, Wei S, Ahn J. Role of antibiotic stress in phenotypic switching to persister cells of antibiotic-resistant Staphylococcus aureus. Ann Microbiol. 2020;70(1):1–8. · DOI · Paper page
  83. Harms A, Maisonneuve E, Gerdes K. Mechanisms of bacterial persistence during stress and antibiotic exposure. Science. 2016;354(6318):aaf4268. · DOI · Paper page

Cited by

See all 33

Metadata

Authors
Al-Momani, H., Aolymat, I., Ibrahim, L., Albalawi, H., Al Balawi, D., Albiss, B. A., Almasri, M., & Alghweiri, S.
Venue
BMC Microbiology
Published
2024-08-03
Volume
24
Issue
1
ISSN
1471-2180
Cited by
33
References
3
Language
en
Licence
Funders
The Department of scintifc reaserch at The Hashemite University/Jordan.

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.